0001209191-11-039834.txt : 20110718
0001209191-11-039834.hdr.sgml : 20110718
20110718192533
ACCESSION NUMBER: 0001209191-11-039834
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110414
FILED AS OF DATE: 20110718
DATE AS OF CHANGE: 20110718
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSITE VISION INC
CENTRAL INDEX KEY: 0000802724
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943015807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 965 ATLANTIC AVE
STREET 2: --
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 5108658800
MAIL ADDRESS:
STREET 1: 965 ATLANTIC AVE
STREET 2: ---
CITY: ALAMEDA
STATE: CA
ZIP: 94501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coliseum Capital Management, LLC
CENTRAL INDEX KEY: 0001409751
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22332
FILM NUMBER: 11973603
BUSINESS ADDRESS:
STREET 1: 767 THIRD AVENUE
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-488-5555
MAIL ADDRESS:
STREET 1: 767 THIRD AVENUE
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
c20021_4x0.xml
MAIN DOCUMENT DESCRIPTION
X0303
4
2011-04-14
0000802724
INSITE VISION INC
INSV
0001409751
Coliseum Capital Management, LLC
767 THIRD AVENUE
35TH FLOOR
NEW YORK
NY
10017
0
0
1
0
Common Stock
2011-04-14
4
P
0
41200
0.91
A
9685673
I
See Footnote
Common Stock
2011-04-18
4
P
0
36050
0.89
A
9721723
I
See Footnote
Common Stock
2011-04-25
4
P
0
132815
0.80
A
9854538
I
See Footnote
Common Stock
2011-07-12
4
P
0
5000000
A
14854538
I
See Footnote
Common Stock Warrants (right to buy)
0.75
2011-07-12
4
P
0
2000000
A
2011-07-18
2016-07-18
Common Stock
2000000
2000000
I
See Footnote
These securities are held directly by (a) Coliseum Capital Partners, L.P., an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, and (b) Blackwell Partners, LLC ("Blackwell"), a separate account investment advisory client of CCM. Christopher Shackelton and Adam Gray manage CCM and CC. Each of Christopher Shackelton, Adam Gray, Blackwell, CCP, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $0.88 to $0.92. The reported price reflects the weighted average purchase price. The Reporting Person filing this report hereby undertakes to provide upon request by the SEC staff, Insite Vision, Inc. or a shareholder of Insite Vision, Inc. full information regarding the number of shares purchased at each separate price.
This transaction was executed in multiple trades at prices ranging from $0.87 to $0.92. The reported price reflects the weighted average purchase price. The Reporting Person filing this report hereby undertakes to provide upon request by the SEC staff, Insite Vision, Inc. or a shareholder of Insite Vision, Inc. full information regarding the number of shares purchased at each separate price.
This transaction was executed in multiple trades at a price of $0.80. The reported price reflects the weighted average purchase price. The Reporting Person filing this report hereby undertakes to provide upon request by the SEC staff, Insite Vision, Inc. or a shareholder of Insite Vision, Inc. full information regarding the number of shares purchased at each separate price.
On July 12, 2011, CCM purchased 5,000,000 unregistered shares of Common Stock and warrants to purchase 2,000,000 shares of Common Stock from the Issuer in a private placement transaction for a total purchase price of $3,000,000.
/s/ Christopher Shackelton, Manager
2011-07-18